Revolution Medicines, Inc. (RVMDW) stock
RVMDWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMD
$9.81+0.18 (+1.82%)
Close on Oct 30, 2026Market cap $41.00BP/E –Yield –
Revolution Medicines price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Revolution Medicines's price to book ratio was 15.0× on Oct 19, 2026, against 5.9× a year earlier. Over the last 5 years it ranged from 2.3× to 25.0×, with a median of 3.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 15.0× | +5.5 |
| 2025 | Dec 31, 2025 | 9.5× | +4.8 |
| 2024 | Dec 31, 2024 | 4.7× | +0.9 |
| 2023 | Dec 29, 2023 | 3.7× | +0.7 |
| 2022 | Dec 30, 2022 | 3.1× | +0.2 |
| 2021 | Dec 31, 2021 | 2.9× | −2.3 |
| 2020 | Dec 31, 2020 | 5.2× | – |